Takeda Oncology
Daniela Orosco Loeza is a seasoned professional in medical communications and oncology with extensive experience in various roles within prominent pharmaceutical companies. Currently serving as a Senior Medical Communications & Digital Manager at Takeda Oncology since April 2023, Daniela previously held positions such as Senior Medical Communication Advisor Oncology and Medical Communication Advisor Oncology at Takeda. Daniela's career also includes roles as a Medical Science Liaison in hematology and oncology at Roche, as well as experience as a Clinical Research Manager at Novartis Pharma. Daniela began in medical research while completing a doctorate in biological studies focused on skin cancer research at Biozentrum Würzburg. Academic qualifications were attained at Uni Ulm and Uni Bremen between 2006 and 2008.
This person is not in any teams
This person is not in any offices
Takeda Oncology
20 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.